Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilsenbeck

Showing results (21-30 of 407) with videos related to

Pageof 41
Sort By:
Breast Cancer Research and Treatment|March 27, 1998
IGF system components as prognostic markers in breast cancerA V Lee, S G Hilsenbeck, D Yee
Archives of Orthopaedic and Trauma Surgery|December 17, 2003
New concepts in the treatment of ankle joint fractures. The IP-XS (XSL) and IP-XXS (XXSL) nail in the treatment of ankle joint fracturesJ Gehr, W Neber, F Hilsenbeck, et al.
Breast Cancer Research and Treatment|January 1, 1992
Why do so many prognostic factors fail to pan out?S G Hilsenbeck, G M Clark, W L McGuire
American Journal of Clinical Oncology|August 1, 1993
Prognostic factors in lung cancer based on multivariate analysisS G Hilsenbeck, W A Raub, K S Sridhar
Health Informatics Journal|June 18, 2025
A hybrid cloud data lake architecture supporting the integration of clinical and genomics dataApollo McOwiti, Heidi Dowst, Fei Zheng, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 14, 2002
Sp1 is essential for estrogen receptor alpha gene transcriptionLinda A deGraffenried, Susan G Hilsenbeck, Suzanne A W Fuqua
Cancer Investigation|January 1, 1992
Five-drug antiemetic combination for cisplatin chemotherapyK S Sridhar, A M Hussein, S Hilsenbeck, et al.
British Journal of Cancer|February 17, 2005
Genomic approaches in the management and treatment of breast cancerJ C Chang, S G Hilsenbeck, S A W Fuqua
Breast Cancer Research : BCR|July 1, 2005
The promise of microarrays in the management and treatment of breast cancerJenny C Chang, Susan G Hilsenbeck, Suzanne A W Fuqua
Breast Disease|February 3, 2005
Genomic approaches to understanding and treating breast cancerSuzanne A W Fuqua, Jenny C Chang, Susan G Hilsenbeck
Pageof 41

Showing results (21-30 of 407) with videos related to

Sort By:
Pageof 41
Breast Cancer Research and Treatment|March 27, 1998
IGF system components as prognostic markers in breast cancerA V Lee, S G Hilsenbeck, D Yee
Archives of Orthopaedic and Trauma Surgery|December 17, 2003
New concepts in the treatment of ankle joint fractures. The IP-XS (XSL) and IP-XXS (XXSL) nail in the treatment of ankle joint fracturesJ Gehr, W Neber, F Hilsenbeck, et al.
Breast Cancer Research and Treatment|January 1, 1992
Why do so many prognostic factors fail to pan out?S G Hilsenbeck, G M Clark, W L McGuire
American Journal of Clinical Oncology|August 1, 1993
Prognostic factors in lung cancer based on multivariate analysisS G Hilsenbeck, W A Raub, K S Sridhar
Health Informatics Journal|June 18, 2025
A hybrid cloud data lake architecture supporting the integration of clinical and genomics dataApollo McOwiti, Heidi Dowst, Fei Zheng, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 14, 2002
Sp1 is essential for estrogen receptor alpha gene transcriptionLinda A deGraffenried, Susan G Hilsenbeck, Suzanne A W Fuqua
Cancer Investigation|January 1, 1992
Five-drug antiemetic combination for cisplatin chemotherapyK S Sridhar, A M Hussein, S Hilsenbeck, et al.
British Journal of Cancer|February 17, 2005
Genomic approaches in the management and treatment of breast cancerJ C Chang, S G Hilsenbeck, S A W Fuqua
Breast Cancer Research : BCR|July 1, 2005
The promise of microarrays in the management and treatment of breast cancerJenny C Chang, Susan G Hilsenbeck, Suzanne A W Fuqua
Breast Disease|February 3, 2005
Genomic approaches to understanding and treating breast cancerSuzanne A W Fuqua, Jenny C Chang, Susan G Hilsenbeck
Pageof 41